Systemic Sclerosis and Serum Content of Transforming Growth Factor.
In conclusion, systemic sclerosis does not seem a disease that would be accompanied by a specific enhancement of serum TGF-β1. Thus, this cytokine is rather unlikely to play an essential role in the development and course of the disease, nor can it be considered diagnostic or prognostic marker.
PMID: 30758773 [PubMed - as supplied by publisher]
Source: Advances in Experimental Medicine and Biology - Category: Research Tags: Adv Exp Med Biol Source Type: research
More News: Biology | Interstitial Lung Disease | Raynaud's Phenomenom | Research | Scleroderma | Skin | Study | Women